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A new human breast cancer cell line, KPL-1 secretes tumour-associated
antigens and grows rapidly in female athymic nude mice
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Summary We recently established a new human breast cancer cell line, designated KPL-1, which was derived
from the malignant effusion of a patient with breast cancer. This cell line is highly tumorigenic and grows
rapidly in female nude mice. Cytogenetic analysis indicated its human origin and revealed a hypertriploid
modal number of chromosomes. Electron microscopic examination suggested that the KPL-1 cells are of
epithelial origin. Immunohistochemical studies revealed that the cells express cytokeratin, carcinoembryonic
antigen and CA 15-3. They also possess a large number of oestrogen receptors but not progesterone receptors.
Interestingly, KPL-1 cells seem to grow oestrogen independently in vitro. No amplification of c-erbB-2, c-myc,
H-ras and N-ras genes was detected. KPL-1 cells secrete a large amount of tissue polypeptide antigen (TPA).
Although the secretion of CA 15-3 seemed to be constant throughout all cell growth phases, TPA secretion
increased during the exponential growth phase and decreased during the plateau phase. Serum TPA levels
significantly correlated with the volume of KPL-1 tumours transplanted into nude mice. These data suggest
that this KPL-1 cell line may be useful for studying oestrogen-independent growth and the kinetics of
tumour-associated antigens in vivo as well as in vitro.
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Well-characterised cancer cell lines are powerful research
resources for studying cancer cell biology and for the
development of new strategies against cancer. In addition,
cancer cell lines which are tumorigenic in athymic nude mice
are useful models for testing newly developed anti-tumour
agents in vivo.
Many breast cancer cell lines have been established, mainly
from the malignant effusions of patients with advanced
breast cancer. Such effusions are considered as a good source
of viable tumour cells with little contamination by stromal
cells, which often interfere with the growth of tumour cells in
vitro (Soule, et al., 1973; Calleau et al., 1974; Engel et al.,
1978).
The present report describes the establishment and prelim-
inary characterisation of a new breast cancer cell line, desig-
nated KPL-1, which was derived from the malignant pleural
effusion of a patient with recurrent breast cancer and has
been maintained for over 50 passages. This cell line secretes a
large amount of tumour-associated antigens, in particular
tissue polypeptide antigen (TPA) (Luning et al., 1980; Bjork-
lund and Bjorklund, 1983), and also grows rapidly in female
athymic nude mice. TPA has been used as a serum tumour
marker for monitoring the clinical course of patients with
breast cancer (Nemoto et al., 1979; Mross and Bandlow,
1986; Gion et al., 1990a). Furthermore, cytosolic TPA in
patients with breast cancer has recently been suggested to be
of prognostic importance (Gion et al., 1990b). To investigate
the kinetics of tumour-associated antigens, the secretion of
TPA and CA 15-3 (Kufe et al., 1984; Hayes et al., 1986; Abe
and Kufe, 1987) was measured through cell growth phases in
this cell line.
Materials and methods
Patient and cell culture
A 50-year-old Japanese woman with a primary breast cancer
underwent a modified radical mastectomy in March 1989.
The histological diagnosis of the resected specimen was
invasive ductal carcinoma of the breast with a predominant
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intraductal component and multiple axillary lymph node
metastases. Several supraclavicular lymph node metastases
were observed in June 1991. The patient received a combined
therapy including chemoendocrine therapy and radiation
therapy from June 1991 to January 1993. The recurrent
disease progressed-with little response to these therapies, and
the patient died of breast cancer in February 1993. An
autopsy revealed the recurrent disease in the skin, supra-
clavicular and mediastinal lymph nodes, vertebral bones,
thyroid gland, pleura and liver.
Malignant pleural fluid was obtained from the patient in
December 1992. A 50 ml volume of the heparinised fluid was
centrifuged at 150g for 10min. Then the supernatant was
removed and the cell pellet was resuspended and plated in
T-25 flasks (Corning Japan, Tokyo, Japan) containing Dul-
becco's modified essential medium (DMEM) (ICN Biochemi-
cals, Costa Mesa, CA, USA) supplemented with 10% fetal
bovine serum (FBS) (ICN Biochemicals Japan, Osaka,
Japan). Serial passages using 0.05% trypsin (Difco, Detroit,
MI, USA) in phosphate-buffered saline (PBS) were done
once or twice a week. No additional supplements such as
oestradiol, insulin or antibiotics were needed for stable
growth of the KPL-1 cells. Since atypical epithelial cells
predominantly grew in culture during all of the passages and
cytogenetic analysis as described below strongly indicated
that the cells are of monoclonal origin, we have not attempt-
ed to subclone them.
Morphological analysis
Haematoxylin-eosin staining of paraffin-embedded speci-
mens was performed using the conventional method in the
original tumour of the patient, the recurrent tumour which
was obtained in the autopsy and KPL-1 tumours trans-
planted into nude mice. Five per cent buffered-formalin was
used as the fixative. Cytological examination of pleural
effusion obtained from the patient was also performed. After
centrifugation of the effusion at 150g for 5 min, smears were
made from the cell deposit onto a glass slide. The smears
were stained by the conventional Papanicolaou's method.
Photographs were obtained with an Olympus AH-2 micro-
scope (Olympus, Tokyo, Japan).
Cultured KPL-1 cells in a T-25 flask were observed and
phase-contrast microphotographs taken with an inverted
Nikon Diaphot-TMD microscope (Nikon, Tokyo, Japan).KPLR1 human breast cancercell line
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For transmission electron microscopy, KPL-1 tumours
that had been transplanted into nude mice were resected,
minced into 1 mm in size and fixed with 2.5% glutaraldehyde
(Sigma, St Louis, MO, USA) in PBS for 2 h at 4°C. After
washing with PBS, the blocks were post-fixed with 1%
osmium tetroxide in 0.1 M cacodylate buffer and embedded in
epoxy resin. These were cut into thin sections with a Super-
nova ultracutter (Reichert-Jung, Wien, Austria) with a
diamond knife, stained with uranyl acetate and lead citrate,
and examined with a Hitachi H-7100 electron microscope
(Hitachi Electronics, Tokyo, Japan).
For immunohistochemical study, paraffin sections of the
tumour samples were dewaxed in xylene, hydrated with PBS,
treated with hydrogen peroxide for elimination of endo-
genous peroxidase and then processed by the immunoperox-
idase procedure. A rabbit anti-cytokeratin (Milab, Tokyo,
Japan), anti-CEA (Milab), anti-CA 15-3 (Turner, Tokyo,
Japan), anti-vimentin (Dako Japan, Tokyo, Japan) and anti-
erbB-2 oncoprotein (Triton Biosciences, Alameda, CA, USA)
were used as the first antibodies. Control experiments were
performed by substituting normal serum for the first
a
antibodies. The reaction was visualised by streptavi-
din-biotin (Nichirei, Tokyo, Japan) techniques following the
manufacturer's recommendations. The sections were also
counterstained with methyl green.
Chromosomal analysis
Cytogenetic analysis was performed when the cell line had
been passed 24 times. Semiconfluent cells were exposed to
0.1 g ml1' colcemid for 4 h and then detached with' trypsin.
A hypotonic solution of 0.075 M potassium chloride was
added, and then the cells were fixed with 3:1 methanol-
acetic acid and stained conventionally with Giemsa.
Receptor analysis
Oestrogen receptor (ER) and progesterone receptor (PR)
status were measured by an enzyme immunoassay (EIA)
using the ER-EIA and PgR-EIA Abbott kits (Dinabot,
Tokyo, Japan) following the manufacturer's recommenda-
tions and also by a conventional radioreceptor assay using
h
Figure 1 Light microscopic-and phase-contrast microscopic ana-
lysis of KPL-1 cells. (a) Cytological examination of smears
obtained from pleural effusion of the patient (Papanicolaou's
staining, original x 100). (b) A phase-contrast photograph of
confluent KPL-1 cells in a T-25 flask (original x 100). (c)
Haematoxylin and eosin-stained section from the original tumour
of the patient (original x 100). (d) Haematoxylin and eosin stain-
ing of a section from recurrent disease in soft tissue obtained in
the autopsy of the patient (original x 40). (e) Haematoxylin and
eosin staining of a section of KPL-1 tumours transplanted into
nude mice (original x 100).
846['25l17p-oestradiol and ['25I]R5020 (New England Nuclear,
Boston, MA, USA) as the respective ligands as described
previously (Kurebayashi et al., 1990). Epidermal growth fac-
tor receptor (EGFR) in membrane fractions of the tumours
was determined by a radioreceptor assay using ['25I]EGF
(New England Nuclear) as the ligand as described by Yasui
et al. (1988).
Oncogene amplification
Total cellular DNA was extracted by a conventional phenol-
chloroform method. DNA dot-blot hybridisation was per-
formed as described by Kinoshita et al. (1993). DNA samples
were spotted onto Hybond N nylon sheets (Amersham, Arl-
ington Heights, IL, USA) using a Hybri-dot blotting
manifold (BRL, Bethesda, MD, USA). The sheets were then
hybridised with 32P-labelled specific DNA probes and expos-
ed to X-ray films. Hybridisation signals were analysed with a
BSA2000 bioimaging analyser (Fuji Film, Tokyo, Japan).
The degree of oncogene amplification was estimated by com-
parison with the radioactivity of placental DNA on the same
membrane. The actin probe was used as an internal control
for determination of the amount of DNA in each dot on the
membrane. The DNA probes were a 1.6 kb EcoRI fragment
of human erbB-2, a 1.8 kb fragment of the EcoRI-Clal third
exon fragment ofc-myc, a 3.7 kb Sacl fragment of H-ras and
a 2.0 kb fragment of the PvuII fragment of N-ras. All DNA
probes were obtained from Otsuka Pharmaceutical (Toku-
shima, Japan).
a
b
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Cellgrowth in vitro and in vivo
Approximately 1 x 105 cells per well were plated in 12-well
plates (SB Medical, Tokyo, Japan) and grown in DMEM
supplemented with 10% FBS for two weeks at 37°C in a 5%
carbon dioxide atmosphere. Triplicate wells were trypsinised
at the times indicated and the viable cells were counted in a
haemocytometer using trypan blue exclusion. The tumour
doubling time in vitro was estimated from the linear portion
of the growth curve.
To investigate the oestrogen-responsiveness of the KPL-1
cells in vitro, 1 x IO0 cells per well were plated in the 12-well
plates and grown in phenol red-free RPMI-1640 medium
(Gibco BRL, Tokyo, Japan) supplemented with 2% dextran-
coated charcoal treated-FBS (Scholl et al., 1983) at 37°C in a
5% carbon dioxide atmosphere. 17P-Oestradiol 1 x 10-6 M
(E2, Sigma) and tamoxifen 1 x 10-4 M (TAM, Zeneca Phar-
maceuticals, Macclesfield, UK) were prepared as concentra-
ted stocks in 100% ethanol and diluted 1:1000 (v/v) into the
culture medium. The final ethanol concentrations was 0.1%.
At this concentration the vehicle did not alter the growth of
the KPL-1 cells. The culture medium was changed every
other day. Triplicated wells were trypsinised 7 days after the
cell inoculations and the viable cells were counted in a
haemocytometer using trypan blue exclusion.
Semiconfluent KPL-1 cells were trypsinised and harvested.
Viable cells were counted in a haemocytometer using trypan
blue exclusion and centrifuged. Cell pellets were resuspended
with medium and the cell density was adjusted to the desired
level. Then 1 x, 5 x and 10 x 106 viable cells/0.2 ml of the
medium were injected into the mammary fat pad (two injec-
tions per mouse) of 4- to 6-week-old Balb/c nu/nu female
athymic nude mice (Clea Japan, Tokyo, Japan). Tumour
volume was calculated as the product of the largest diameter,
the orthogonal measurement and the tumour depth. Mean
tumour volume was calculated as the sum of tumour volumes
divided by the number of tumours.
Measurement oftumour-associated antigens
TPA was measured in serum of the patient and nude mice
transplanted with the KPL-1 cells, pleural effusion and
medium by an RIA kit (AB Sangtec Medical, Bromma,
Sweden), CA 15-3 by an RIA kit (Centcor, Malven, PA,
USA), and CEA by an enzyme immunoassay kit (Dinabot,
Tokyo, Japan). The coefficients of intra- and inter-assay
variations were not higher than 10.8% for all the three
marker levels (data not shown).
The concentration of these antigens in KPL-1 tumours
resected from nude mice was also measured as follows: 0.2 g
ofeach tumour was homogenised by a Polytron homogeniser
with 2.0 ml of saline and the concentration of the antigens in
the supernatant was measured by the same method as des-
cribed above.
To estimate the amount of secretion of TPA and CA 15-3
from the KPL-1 cells, the cells were washed twice with PBS
after removal of medium. Then fresh medium was added,
and the cells were incubated for a day. Next, the medium
was collected and the concentrations of TPA and CA 15-3 in
the medium were measured by the same method as described
above. Because the concentration of these tumour-associated
antigens in the fresh medium was undetectable and the anti-
genicities were stable for at least a day (data not shown), the
secretion per cell per day was calculated as follows:
Secretion per cell per day =
concentration ofeach marker
x volume ofmedium
mean cell number
Figure 2 Electron microscopic analysis of KPL-I tumours re-
sected from nude mice. (a) Electron micrograph showing an
intracytoplasmic lumen with protruding microvilli (original
x 9000). (b) Electron micrograph showing junctional structures
(desmosomes, arrows) between the tumour cells (original
x 3000). Bars = 1 lsm.
Results
Morphologicalfeatures
Cytological examination of smears obtained from the pleural
effusion revealed small clusters of large, irregular-shapedKPL-1 human breast cancercell line
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atypical cells with round and hyperchromatic nuclei.
Occasionally, large round-shaped inclusions were seen in the
cytoplasm (Figure la).
The KPL-1 cells in culture resemble atypical cells in the
pleural effusion. Each cell is polygonal and possesses a large
nucleus with either a single prominent nucleolus or a few
prominent chromocentres. Occasionally, round-shaped in-
clusions have been observed in the cytoplasm. Basically, the
cells grow in a monolayer fashion like a cobblestone. When
the cells reach confluency, they tend to pile up on each other
(Figure lb).
Histological examination of the original tumour of the
patient revealed a prominent intraductal spread ofpolygonal-
shaped atypical cells with central necrosis (Figure Ic).
Examination of metastatic lesions obtained in the autopsy
a
revealed numerous nests consisting of polygonal-shaped
atypical cells and aspects of invasion into the fatty tissue in
the tumour border (Figure ld). Occasionally, small lumina
were found among the tumour cells in both original and
metastatic tumours.
Histological examination of the KPL-1 tumours trans-
planted into nude mice revealed that relatively demarcated
tumours had formed in the subcutaneous tissue of the nude
mice and showed expansive growth. Numerous small nests of
tumour cells were recognised and small lumina were found
among the tumour cells. Each tumour cell had a round or
oval-shaped nucleus with a large nucleolus, and small intra-
cytoplasmic lumina were often found (Figure le). These find-
ings were similar to those observed in both original and
metastatic tumours of the patient.
d
b
c
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Figure 3 Immunohistochemical analysis of KPL-1 tumours resected from nude mice and the original tumour of the patient. (a)
Immunohistochemical staining of a section from KPL-1 tumours with an antibody against cytokeratin (original x 100). (b)
Immunohistochemical staining of a section from KPL-l tumours with an antibody against CEA (original x 100). (c) Immunohis-
tochemical staining of a section from KPL-1 tumours with an antibody against CA 15-3 (original x 100). (d) Immunohistochemical
staining of a section from the original tumour with an antibody against cytokeratin (original x 100). (e) Immunohistochemical
staining of a section from the original tumour with an antibody against CEA (original x 100). (f) Immunohistochemical staining of
a section from the original tumour with an antibody against CA 15-3 (original x 100).Ultrastructurally, a large oval nucleus with a large nucle-
olus and prominent chromatin was seen in the KPL-1
tumour cells transplanted into nude mice. In the cytoplasm,
many mitochondria and well-developed rough endoplasmic
reticulum were recognised. Large intracytoplasmic lumina
with protruding microvilli were often found in the tumour
cells (Figure 2a). In addition, numerous intermediate fila-
ments distributed in the cytoplasm and junctional structures
(desmosomes) among the tumour cells were recognised
(Figure 2b).
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Figure 4 A histogram of the chromosome number in KPL-1
cells. A total of 40 cells at the 24th passage were studied. The
median chromosome number was 78.
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Immunohistochemical studies
Each tumour cell in the transplanted KPL-1 tumours showed
positive immunoreaction for cytokeratin, CEA and CA 15-3,
but negative immunoreaction for vimentin and erbB-2 onco-
protein. The immunoreactions for cytokeratin and CEA were
demonstrated in the cytoplasm of the tumour cells. On the
other hand, CA 15-3 was mainly detected on the surface
membrane of tumour cells facing intracytoplasmic and inter-
cellular lumina (Figure 3a-c). Interestingly, these findings
were also observed in the original tumour of the patient
(Figure 3d-f).
Karyotype analysis
A total of 40 cells from the KPL-1 cell line at the 24th
passage were studied, and a detailed analysis by the tryp-
sin-Giemsa method was performed in ten metaphases. A
histogram of the chromosome number indicated a median of
78 with a range from 74 to 80 (Figure 4). When G-banding
was performed, 17-25 marker chromosomes were found.
The common aberrations were 2q+, 3p+, Sq+, 6q-, 6q+,
7p-, 7p+, 8p+, 9p+, 10p+, 12q-, 19q+, 22p+ and
Xq+ in all ten metaphases. Normal human chromosomes
were identified; they included numbers 1, 17, 18 and 21.
Chromsome number 20 was not identified (Figure 5). These
findings strongly suggest that this cell line is derived from a
monoclonal human cancer cell.
Receptor analysis andgene amplification
The KPL-1 tumours transplanted into nude mice contained a
relatively large amount of ER measured by both the binding
assay and the enzyme immunoassay. The binding capacity of
ER was 122.1 ± 57.5 femtomol mg-' protein with a dissocia-
tion constant of 7.1 ± 3.2 x 10-10 M (mean ± s.d., n = 3) by
Figure 5 Representative Giemsa-banded karyotypes of the KPL-1 cell line. Chromosome preparation and staining are described in
Materials and methods. Arrows indicate abnormal chromosomes. Eighteen unidentified chromosomes (marker chromosomes) were
observed in this karyotype analysis.KPL-1 human breast cancercell line
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the binding assay. That of ER was 170 femtomolmg-' pro-
tein by the enzyme immunoassay. No PR in the transplanted
tumours was detected by either the binding assay or the
enzyme immunoassay. A small amount of EGFR, that is a
binding capacity of 2.5 ± 2.3 femtomol mg-' protein ofmem-
brane fraction with a dissociation constant of
3.5 ± 1.9 x 10-9 M (mean ± s.d., n = 3), was detected in the
transplanted tumours.
No gene amplification of c-erbB-2, c-myc, H-ras and N-ras
measured by DNA dot-blot hybridisation was seen in the
transplanted KPL-1 tumours. The estimated copy number of
the genes in KPL-1 cells was 0.92 for c-erbB-2, 0.98 for
c-myc, 1.08 for H-ras and 1.12 for N-ras.
Cellgrowth in vitro and in vivo
An anchorage-dependent growth curve at the 24th passage is
shown in Figure 6. The population -doubling time was appro-
ximately 48 h when the cells exponentially grew in DMEM
supplemented with 10% FBS.
As shown in Figure 7, the addition of 10-9M E2 alone,
I07- M tamoxifen alone or both of them into the E2-deficient
medium as described above did not alter the anchorage-
dependent growth of the KPL-1 cells. Similar results were
obtained in three separate experiments.
KPL-1 cells at the 5th, 21st, 25th and 42nd passages were
injected into the mammary fat pads of female athymic nude
mice. The cells from all the passages developed tumours in
the nude mice at a take rate of 100% (4/4 for the 5th
passage, 10/10 for the 21st passage, 18/18 for the 25th pas-
sage and 12/12 for the 42nd passage). When 1 x 106 cells
were injected into the mice at the 25th passage, tumours
could be detected 2 weeks after the injections. In contrast,
when 5 x or 10 x 106 cells were injected, tumours developed
within a week after the injections and grew rapidly, as shown
in Figure 8a. To confirm the stable tumorigenicity of the
KPL-1 cells in the nude mice, 5 x 106 cells were also injected
into female nude mice at the 42nd passage. Tumours deve-
loped within a week after the injections and grew rapidly, as
shown in Figure 8b.
Post-mortem examination revealed that the tumours were
basically well circumscribed, and no macroscopic metastasis
was observed in the lymph nodes, lungs, liver or kidney.
Representative sections cut from paraffin-embedded speci-
mens of the explored organs were stained with haematoxylin-
eosin and observed with a light microscope. During the
experiment using KPL-1 cells at the 24th passage, only three
microscopic metastatic foci (5.6%) were observed at the
periphery of lymph nodes in 54 explored lymph nodes 6
weeks after the cell injections. No metastasis was found in
the lungs, liver or kidney of the nude mice. During the
experiment using KPL-1 cells at the 42nd passage, four
microscopic metastatic foci were observed at both the
periphery and the centre of lymph nodes (33.3%) in 12
explored lymph nodes 9 weeks after the cell injections (Figure
9a and b). Again, no distant metastasis was found.
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Figure 7 Results of a representative experiment to investigate
the oestrogen responsiveness of KPL-1 cells in vitro. Approx-
imately I x 10-9M E2, I X 10-7M TAM or their combination
was added to phenol red-free RPMI-1640 medium supplemented
with 2% dextran-coated charcoal treated-FBS. Approximately
I x I10 cells were plated in 12-well plates and grown in each
medium. Triplicated wells were trypsinised 7 days after the cell
inoculations and the viable cells were counted in a haemocyto-
meter. Values are means ± s.d.
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Figure 6 An anchorage-dependent growth curve of KPL-1 cells
at the 24th passage and the secretion of TPA and CA 15-3 from
the cells. Approximately 1 x l05 cells per well were plated in a
12-well plate and grown in DMEM supplemented with 10% FBS.
Triplicated wells were trypsinised at the times indicated and the
viable cells were counted in a haemocytometer using trypan blue
exclusion. The secretion of TPA and CA 15-3 from KPL-l cells
(secretion per cell per day) was calculated as described in
Materials and methods (n = 3 at each point). 0-0, Mean cell
number ± s.d., *-*, mean TPA secretion per cell per day +
s.d., A A, mean CA 15-3 secretion per cell per day
- s.d.
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Figure 8 Growth of KPL-I tumours in female nude mice. (a)
Approximately 1 x (A), 5 x (-) or 10 x (0) 106 viable KPL-1
cells at the 25th passage were injected into the mammary fat pad
of 4- to 6-week-old athymic nude mice. (b) Approximately
5 x 101 viable KPL-1 cells from the 42nd passage were injected.
The tumour size was measured once a week. The tumour volume
was calculated as described in Materials and methods. Values
represent the mean tumour volume ± s.d. (n = 6 each for the 25th
passage and n = 12 for the 42nd passage).
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ISecretion of tumour-associated antigens
Three tumour-associated antigens, TPA, CA 15-3 and CEA,
were measured in the serum and pleural effusion of the
patient and medium collected from KPL-1 cells cultured in a
T-25 flask for 7 days. As shown in Table I, an extremely high
concentration of TPA was found in all the samples. The
concentration of TPA in the medium was approximately ten
times higher than that in the pleural effusion. In contrast, the
concentrations of CA 15-3 and CEA in the medium were,
respectively, approximately 50 times and seven times lower
than those in the pleural effusion.
To confirm the production of these tumour-associated
antigens from the KPL-1 cells, the antigens were measured in
the supernatant of homogenised KPL-1 tumours resected
from the nude mice. The concentrations of TPA, CA 15-3
and CEA were 12 000 U, 6000 U and 2800 ngg' wet tissue
respectively. Immunohistochemistry using anti-CA 15-3 and
anti-CEA antibody also showed the presence of CA 15-3 and
CEA in the transplanted KPL-1 tumours, as described above
(Figure 2b and c).
To investigate the relationship between the secretion of
tumour-associated antigens and the cell growth phase, the
production of the antigens per cell per day was calculated as
described in Materials and methods at each cell growth phase
including the lag phase, the exponential growth phase and
the plateau phase. Interestingly, TPA secretion from KPL-1
cells rapidly increased during the exponential growth phase
and sharply decreased during the plateau phase, but CA 15-3
secretion was constant throughout the cell growth phases
(Figure 6). The TPA secretion -during the exponential phase
was significantly larger than that during the lag phase or that
during the plateau phase (P<0.01 in each comparison).
a
b
Figure 9 Lymph node metastasis from KPL-I tumours trans-
planted into nude mice. (a) Haematoxylin and eosin-stained sec-
tion from an axillary lymph node in which tumour cells exist at
the periphery of the lymph node (original x 100). (b) Haema-
toxylin and eosin staining of a section from an axillary lymph
node in which tumour cells exist at the centre of the lymph node
(original x 200).
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To study the secretion of TPA from KPL-1 cells in vivo,
serum of the nude mice into which KPL-l cells had been
transplanted was collected and the TPA concentration in the
serum was measured. Interestingly, serum TPA was signifi-
cantly related to the volume of transplanted tumours with a
correlation coefficient of 0.90 for 25th passage and 0.88 for
42nd passage, as shown in Figure lOa and b.
Table I Concentration of tumour-associated antigens in serum and
pleural effusion of the patient and in medium collected from a
culture of KPL-1 cells
Concentration of tumour-associated antigen'
Sample CEA (ngmt') CA 15-3 (Umlt) TPA (U1')
Serumb 58.0 940.0 5.1 x 103
Effusion 46.7 830.0 3.2 x I04
Mediumc 6.6 15.0 3.5 x 105
aThe concentration of each tumour-associated antigen was measured
as described in Materials and methods. bThe normal range of each
serum tumour marker is less than 2.5 ngml-' for CEA, less than
30 U ml- I for CA 15-3 and less than 110 U 1- l for TPA according to
the manufacturer's recommendations. cThe medium was collected
from a 7 day culture of KPL-I cells in a 12-well dish. The final cell
density was approximately half a million cells per ml.
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Figure 10 Correlation of serum TPA levels with the volumes of
KPL-1 tumours transplanted into nude mice. (a) Approximately
1 x, 5 x or 10 x 106 viable KPL-1 cells at the 25th passage were
injected into 4- to 6-week-old female nude mice. Those mice were
sacrificed 6 weeks after the injections and blood was immediately
collected. (b) Approximately 5 x 106 viable KPL-l cells at the
42nd passage were injected into nude mice. Those mice were
sacrificed 9 weeks after the injections and blood was collected.
Serum TPA levels were measured as described in Materials and
methods. These levels linearly rose as the tumours grew.KPL-2 human breastcancercell line
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Discussion
Breast cancer cell lines such as the MCF-7 cell line (Soule et
al., 1973) have contributed greatly to the understanding of
breast cancer cell biology and the development of new thera-
peutic approaches for breast cancer. However, there is a
remarkable heterogeneity among human breast cancers in
terms of hormone responsiveness and genetic alterations
(Wolman and Dawson, 1991; Chen et al., 1992; Horwitz,
1992). For these reasons, the establishment of new and well-
characterised breast cancer cell lines is important.
To confirm that KPL-1 cells were derived from human
breast cancer cells, morphological analysis with light and
electron microscope and cytogenetic, immunohistochemical
and biochemical analyses were conducted. All these data sug-
gested that KPL-1 cells are of epithelial origin and may be
derived from breast cancer. Furthermore, large amounts of
tumour-associated antigens, CEA, CA 15-3 and TPA, were
detected in the serum and pleural effusion of the patient.
Both the secretion of these antigens from these KPL-1 cells
into medium and positive immunoreaction for CA 15-3 and
CEA in the cells suggested that they originated from the
same tumour cells of the patient (Table I and Figure 3).
KPL-1 cells in culture seem to secrete much more TPA than
CA 15-3 or CEA. Although it might be possible that the
metabolism of CA 15-3 and CEA in pleural effusion and
blood circulation differs from that in culture medium, it is
likely that KPL-1 cells preferentially secrete TPA in an
anchorage-dependent culture condition. Further experiments
are needed to clarify and understand this phenomenon.
TPA is a protein antigen composed of more than 200
amino acids with a molecular weight of 17-43 kDa (Luning
et al., 1980). This protein is suggested to be related to
non-epidermal keratins 8, 18 and 19 (Weber et al., 1984).
Production and secretion of TPA from cultured HeLa cells
has been reported to correlate with the early S-phase and the
mitotic phase respectively (Bjorklund and Bjorklund, 1983).
Thus, TPA is thought to be related to proliferative activity in
general. TPA has been found not only in a variety of human
malignancies, including breast cancer, but also in rapidly
growing normal organs such as fetal tissues (Bjorklund and
Bj6rklund, 1983). Accumulated knowledge of TPA indicates
that TPA may be a unique tumour-associated antigen in
malignancies and also may be related to the regulatory
mechanisms of cell growth. Preliminary results in the present
study suggested that KPL-1 cells secrete a larger amount of
TPA during the exponential growth phase than during the
lag phase or the plateau phase. In contrast, the secretion of
CA 15-3 seemed to be independent of any cell growth phase.
Further analysis of KPL-1 cells, including the relationship
between the cell cycle and secretion or production of tumour-
associated antigens, should be done. Interestingly, the serum
TPA concentration could be measured in the nude mice into
which KPL-1 cells had been transplanted and the concentra-
tion linearly correlated with the volume of transplanted
tumours (Figure 10). To the best of our knowledge, KPL-1 is
the first cell line in which serum TPA has been detected in
vivo. This cell line may make it possible to study the kinetics
of tumour markers in vivo as well as in vitro.
It is known that breast cancer cell lines tend to be less
tumorigenic and less metastatic than other cancer cell lines
derived from lung, renal and colon carcinomas and sarcomas
when the cell lines are subcutaneously injected into the flank
of nude mice (Ozzello and Sordat, 1980; Shafie and Liotta,
1980; Price et al., 1990). Recent reports suggest that ortho-
tropic transplantation of cancer cell lines into nude mice is
more tumorigenic and sometimes induces spontaneous metas-
tasis (Fidler, 1991). In the present study, KPL-1 cells were
injected orthotropically into the mammary fat pads of female
nude mice. The tumour take rate of KPL-l cells by this
orthotropic transplantation was 100% and all the trans-
planted tumours grew rapidly (Figure 8). Moreover, micro-
metastases into the lymph nodes could be recognised in the
nude mice with transplanted KPL-1 cells (Figure 9). These
findings support the suggestion that orthotropic transplanta-
tion of cancer cell lines may be useful in creating tumours
and spontaneous metastasis in nude mice.
Expression of ER is one of the most characteristic features
ofbreast cancer. To clarify that KPL-1 cells are derived from
breast cancer, ER in the transplanted KPL-1 tumours was
measured by both the conventional ligand-binding assay and
the enzyme immunoassay. A relatively large number of ERs
were detected in the KPL-1 tumours by both methods. In
contrast, no PRs were detected in the same tumours by these
assays. ER-positive but PR-negative primary breast cancers
are known to occur with a frequency of approximately 20%
(McGuire and Horwitz, 1978). Recent reports suggest that
aberration of a part of the ER gene, such as the DNA-
binding domain, may produce tumours which express ER but
not PR (Murphy and Dotzlaw, 1989; Wang and Miksicek,
1991; Fuqua et al., 1992). Analysis of the ER gene of KPL-l
cells should be carried out to determine why the cells are ER
positive but PR negative.
Another interesting point is that KPL-1 cells seem to grow
oestrogen independently both in vivo and in vitro. The
preliminary results in this study suggest that the anchorage-
dependent growth of KPL-1 cells is not altered by the
physiological concentration of E2, a therapeutic concentra-
tion of an antioestrogen, TAM, or their combination (Figure
7). Further studies, such as an anchorage-independent
growth experiment, are needed to clarify the hormone inde-
pendency of KPL-1 cells in vitro. With regard to in vivo
growth, it is well known that hormone-responsive MCF-7
cells are unable to grow well without oestradiol supplementa-
tion in intact female nude mice because of a low level of
endogenous oestrogen (Soule and McGrath, 1980). This fact
suggests that KPL-1 cells may grow oestrogen independently
in female nude mice or that a low level of endogenous
oestradiol may be sufficient to make KPL-1 cells grow in
female nude mice. To address these questions, animal
experiments using ovariectomised nude mice are underway.
Recently, some variants of the MCF-7 cell line have been
reported to be ER positive but grow oestrogen independently
in nude mice (Gottardis and Jordan, 1988; Clarke et al.,
1989; McLeskey et al., 1993). One of these variants, the
MKS-1 cell line, which overexpresses fibroblast growth factor
4, has been reported to show rapid growth in ovariectomised
nude mice and maintain the expression of ER (McLeskey et
al., 1993). These findings suggest that activation of signal
transduction via a certain growth factor or oncogene may
influence the hormone dependency of breast cancer cell
growth. To address this question, we investigated gene
amplification of c-erbB-2, c-myc, H-ras and N-ras and exp-
ression of EGFR in KPL-1 cells. No amplification of any of
the genes was detected in KPL-1 cells. Only a small amount
of EGFR was detected. Further studies should be carried out
to clarify the oestrogen independency of KPL-1 cells and
elucidate its mechanisms.
In conclusion, we established a new human breast cancer
cell line designated KPL-1 from the malignant effusion of a
Japanese patient with recurrent breast cancer. Morpho-
logical, cytogenetic and biochemical analyses supported the
conclusion that this cell line is derived from breast cancer.
Preliminary characterisation of KPL-1 cells showed that this
cell line possesses a large number of ERs but grows oestro-
gen independently in vitro. Furthermore, this cell line is
highly tumorigenic in female athymic nude mice. Secretion of
three tumour-assocaited antigens, CEA, CA 15-3 and TPA,
was observed in vivo as well as in vitro. This cell line may be
useful for studying not only the hormone independency of
breast cancer but also the kinetics of tumour-associated
antigens. Further characterisation of the KPL-1 cell line
should be carried out in the near future.
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